The Board of China NT Pharma Group Company Limited announced that Mr. Yu Tze Shan Hailson has been appointed as an independent non-executive Director, the chairman of the Remuneration Committee and a member of the Audit Committee and the Nomination Committee with effect from June 29, 2017. The Board further announced that Mr. Yue Nien Martin Tang has resigned from his position as an independent non-executive Director, the chairman of the Remuneration Committee and a member of the Audit Committee and the Nomination Committee with effect from June 29, 2017. Mr. Yu served as equipment maintenance and testing engineer, equipment maintenance and testing laboratory manager, computer engineering and systems engineering manager of Ampex Ferrotec Limited in Hong Kong successively from June 1979 to September 1987. He joined China International Trust & Investment Corporation Hong Kong (Holdings) Limited and served as general manager of engineering research and development department and consultant of Petroleum Development and LPG Tank Terminal Port successively from October 1987 to January 1998. He has been serving as deputy managing director of Versitech Limited, and deputy director of Technology Transfer Office of the University of Hong Kong since February 1998. Since November 2013, Mr. Yu has been serving as an independent non-executive director of China Traditional Chinese Medicine Holdings Co., Limited formerly known as Winteam Pharmaceutical Group Limited, a company listed on The Stock Exchange of Hong Kong Limited. He has also been serving as an independent non-executive director of Sinopharm Group Co. Ltd., a company listed on the Stock Exchange since September 2014. Mr. Yu is currently a Charted Engineer, fellow of each of the Institute of Electrical Engineers, Hong Kong Institution of Engineers, the Chartered Institute of Arbitrators and Hong Kong Institute of Arbitrators.